Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Palliative Care | 32 | 2024 | 2176 | 1.970 |
Why?
|
| Advance Care Planning | 3 | 2023 | 93 | 1.610 |
Why?
|
| Advance Directives | 3 | 2023 | 89 | 1.010 |
Why?
|
| Genital Neoplasms, Female | 3 | 2023 | 794 | 1.000 |
Why?
|
| Hospital Rapid Response Team | 1 | 2022 | 38 | 0.800 |
Why?
|
| Neoplasms | 30 | 2024 | 15949 | 0.770 |
Why?
|
| Medical Oncology | 4 | 2019 | 1464 | 0.690 |
Why?
|
| Clinical Decision-Making | 3 | 2024 | 536 | 0.680 |
Why?
|
| Professional-Family Relations | 2 | 2017 | 132 | 0.630 |
Why?
|
| Terminal Care | 6 | 2018 | 467 | 0.560 |
Why?
|
| Pain | 10 | 2022 | 1701 | 0.550 |
Why?
|
| Hospices | 2 | 2016 | 51 | 0.550 |
Why?
|
| Cancer Care Facilities | 7 | 2021 | 907 | 0.530 |
Why?
|
| Hospice Care | 1 | 2016 | 163 | 0.470 |
Why?
|
| Outpatients | 4 | 2023 | 458 | 0.440 |
Why?
|
| Documentation | 2 | 2019 | 213 | 0.420 |
Why?
|
| Communication | 6 | 2019 | 841 | 0.410 |
Why?
|
| Resuscitation Orders | 3 | 2010 | 70 | 0.400 |
Why?
|
| Oxycodone | 3 | 2000 | 29 | 0.380 |
Why?
|
| Critical Care | 1 | 2017 | 794 | 0.370 |
Why?
|
| Fever | 2 | 2006 | 516 | 0.370 |
Why?
|
| National Cancer Institute (U.S.) | 3 | 2021 | 219 | 0.360 |
Why?
|
| Decision Making | 5 | 2022 | 1249 | 0.330 |
Why?
|
| Patient Participation | 3 | 2023 | 454 | 0.320 |
Why?
|
| Caregivers | 1 | 2015 | 758 | 0.310 |
Why?
|
| Electronic Health Records | 3 | 2020 | 852 | 0.310 |
Why?
|
| Morphine | 2 | 2000 | 331 | 0.300 |
Why?
|
| Patient Care Planning | 3 | 2022 | 300 | 0.280 |
Why?
|
| Hot Flashes | 1 | 2006 | 34 | 0.270 |
Why?
|
| Referral and Consultation | 3 | 2009 | 930 | 0.260 |
Why?
|
| Health Personnel | 2 | 2024 | 650 | 0.250 |
Why?
|
| Analgesics, Opioid | 5 | 2017 | 1467 | 0.240 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2004 | 13 | 0.240 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2010 | 165 | 0.230 |
Why?
|
| Humans | 50 | 2024 | 270637 | 0.230 |
Why?
|
| Sweating | 1 | 2002 | 9 | 0.210 |
Why?
|
| Program Development | 2 | 2000 | 257 | 0.200 |
Why?
|
| Data Collection | 1 | 2004 | 601 | 0.200 |
Why?
|
| Pelvic Neoplasms | 1 | 2003 | 200 | 0.190 |
Why?
|
| Abdominal Neoplasms | 1 | 2003 | 251 | 0.190 |
Why?
|
| Intestinal Obstruction | 1 | 2003 | 224 | 0.180 |
Why?
|
| Delirium | 3 | 2017 | 208 | 0.180 |
Why?
|
| Pediatrics | 2 | 2012 | 1194 | 0.180 |
Why?
|
| Burnout, Professional | 1 | 2024 | 222 | 0.180 |
Why?
|
| Internet | 1 | 2024 | 687 | 0.170 |
Why?
|
| Female | 28 | 2024 | 148834 | 0.170 |
Why?
|
| Pandemics | 3 | 2024 | 1607 | 0.170 |
Why?
|
| Emotions | 3 | 2022 | 556 | 0.160 |
Why?
|
| Goals | 2 | 2016 | 186 | 0.160 |
Why?
|
| Community Health Services | 1 | 2000 | 127 | 0.160 |
Why?
|
| Physician-Patient Relations | 4 | 2018 | 732 | 0.160 |
Why?
|
| Patient Care Team | 3 | 2017 | 824 | 0.150 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2003 | 629 | 0.150 |
Why?
|
| Lorazepam | 1 | 2017 | 40 | 0.150 |
Why?
|
| Male | 23 | 2024 | 128446 | 0.140 |
Why?
|
| Haloperidol | 1 | 2017 | 70 | 0.140 |
Why?
|
| Anti-Anxiety Agents | 1 | 2017 | 100 | 0.140 |
Why?
|
| Pain Management | 2 | 2017 | 716 | 0.140 |
Why?
|
| Social Support | 2 | 2017 | 585 | 0.140 |
Why?
|
| Fellowships and Scholarships | 1 | 2000 | 417 | 0.130 |
Why?
|
| Telemedicine | 1 | 2023 | 553 | 0.130 |
Why?
|
| Pain Measurement | 5 | 2010 | 1021 | 0.130 |
Why?
|
| Adult | 18 | 2024 | 82023 | 0.130 |
Why?
|
| Mind-Body Therapies | 1 | 2014 | 29 | 0.120 |
Why?
|
| Leadership | 1 | 2017 | 270 | 0.120 |
Why?
|
| Retrospective Studies | 7 | 2022 | 39954 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2000 | 703 | 0.120 |
Why?
|
| Ohio | 3 | 2004 | 116 | 0.120 |
Why?
|
| Quality of Life | 4 | 2023 | 4806 | 0.120 |
Why?
|
| Terminally Ill | 2 | 2008 | 97 | 0.110 |
Why?
|
| Qualitative Research | 1 | 2017 | 638 | 0.110 |
Why?
|
| Spirituality | 1 | 2014 | 129 | 0.110 |
Why?
|
| Ambulatory Care | 3 | 2024 | 592 | 0.110 |
Why?
|
| Bereavement | 2 | 2012 | 31 | 0.110 |
Why?
|
| Antipsychotic Agents | 1 | 2017 | 429 | 0.110 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 455 | 0.110 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2006 | 128 | 0.100 |
Why?
|
| Cancer Pain | 1 | 2017 | 345 | 0.100 |
Why?
|
| Patient Preference | 1 | 2014 | 230 | 0.100 |
Why?
|
| Middle Aged | 19 | 2024 | 90495 | 0.100 |
Why?
|
| Severity of Illness Index | 4 | 2015 | 4391 | 0.100 |
Why?
|
| Aged | 15 | 2024 | 73579 | 0.100 |
Why?
|
| Interprofessional Relations | 2 | 2004 | 207 | 0.090 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 783 | 0.090 |
Why?
|
| Prospective Studies | 6 | 2024 | 13406 | 0.090 |
Why?
|
| Acute Disease | 1 | 2015 | 2491 | 0.090 |
Why?
|
| Adolescent | 7 | 2022 | 32687 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 1995 | 924 | 0.080 |
Why?
|
| Defecation | 1 | 2009 | 58 | 0.080 |
Why?
|
| Injections, Intravenous | 2 | 2000 | 590 | 0.080 |
Why?
|
| Naltrexone | 1 | 2009 | 99 | 0.080 |
Why?
|
| Databases as Topic | 1 | 2008 | 135 | 0.080 |
Why?
|
| Medical Audit | 1 | 2009 | 194 | 0.080 |
Why?
|
| Conscious Sedation | 1 | 2008 | 101 | 0.080 |
Why?
|
| Narcotic Antagonists | 1 | 2009 | 155 | 0.070 |
Why?
|
| Constipation | 1 | 2009 | 189 | 0.070 |
Why?
|
| Hypnotics and Sedatives | 1 | 2008 | 211 | 0.070 |
Why?
|
| United States | 5 | 2021 | 15813 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 2656 | 0.070 |
Why?
|
| Progestins | 1 | 2006 | 92 | 0.070 |
Why?
|
| Body Temperature Regulation | 1 | 2006 | 39 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2000 | 1592 | 0.060 |
Why?
|
| Child | 4 | 2022 | 30558 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2011 | 1184 | 0.060 |
Why?
|
| Young Adult | 6 | 2022 | 22238 | 0.060 |
Why?
|
| Complementary Therapies | 1 | 2006 | 120 | 0.060 |
Why?
|
| Analgesics | 3 | 2010 | 406 | 0.060 |
Why?
|
| Forms and Records Control | 1 | 2004 | 24 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 5053 | 0.060 |
Why?
|
| Parents | 1 | 2012 | 1083 | 0.060 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2008 | 347 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2006 | 215 | 0.060 |
Why?
|
| Aged, 80 and over | 8 | 2017 | 31110 | 0.060 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 334 | 0.060 |
Why?
|
| Job Satisfaction | 1 | 2024 | 121 | 0.050 |
Why?
|
| Computers | 1 | 2023 | 132 | 0.050 |
Why?
|
| Thioridazine | 1 | 2002 | 5 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 2 | 2015 | 616 | 0.050 |
Why?
|
| Patient Admission | 1 | 2004 | 231 | 0.050 |
Why?
|
| Cimetidine | 1 | 2002 | 28 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2004 | 306 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 453 | 0.050 |
Why?
|
| Baths | 1 | 2002 | 17 | 0.050 |
Why?
|
| Continuity of Patient Care | 1 | 2004 | 206 | 0.050 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 5916 | 0.050 |
Why?
|
| Cryotherapy | 1 | 2002 | 67 | 0.050 |
Why?
|
| Histamine H2 Antagonists | 1 | 2002 | 57 | 0.050 |
Why?
|
| Causality | 1 | 2002 | 173 | 0.050 |
Why?
|
| Somatostatin | 1 | 2002 | 121 | 0.050 |
Why?
|
| Body Temperature | 1 | 2002 | 163 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2002 | 4837 | 0.050 |
Why?
|
| Dyspnea | 1 | 2004 | 420 | 0.050 |
Why?
|
| Symptom Assessment | 1 | 2023 | 271 | 0.050 |
Why?
|
| Double-Blind Method | 3 | 2017 | 2570 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 294 | 0.040 |
Why?
|
| Eligibility Determination | 1 | 2000 | 85 | 0.040 |
Why?
|
| Texas | 4 | 2015 | 6445 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2000 | 68 | 0.040 |
Why?
|
| Autonomic Nerve Block | 1 | 1989 | 14 | 0.040 |
Why?
|
| Endocrine System Diseases | 1 | 2000 | 89 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2004 | 2855 | 0.040 |
Why?
|
| Family Health | 1 | 2000 | 347 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 2000 | 157 | 0.040 |
Why?
|
| World Health Organization | 1 | 2000 | 321 | 0.040 |
Why?
|
| Hematologic Diseases | 1 | 2000 | 255 | 0.040 |
Why?
|
| Research | 1 | 2000 | 421 | 0.040 |
Why?
|
| Fatigue | 1 | 2004 | 1290 | 0.040 |
Why?
|
| Physician's Role | 1 | 2000 | 228 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2000 | 234 | 0.040 |
Why?
|
| Pain, Intractable | 1 | 1989 | 180 | 0.040 |
Why?
|
| Ovarian Neoplasms | 2 | 2014 | 4809 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2024 | 1038 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2023 | 878 | 0.030 |
Why?
|
| Cytokines | 1 | 2006 | 2803 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2000 | 436 | 0.030 |
Why?
|
| Attitude to Death | 2 | 2012 | 102 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2000 | 515 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2000 | 762 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 4493 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 9053 | 0.030 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2014 | 155 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 898 | 0.030 |
Why?
|
| Hospital Mortality | 2 | 2012 | 1233 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 3187 | 0.030 |
Why?
|
| APACHE | 1 | 2012 | 92 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2009 | 17071 | 0.030 |
Why?
|
| Psychotherapy | 1 | 2014 | 249 | 0.030 |
Why?
|
| Home Care Services | 1 | 1993 | 99 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 2343 | 0.020 |
Why?
|
| Prognosis | 2 | 2024 | 22527 | 0.020 |
Why?
|
| Focus Groups | 1 | 2012 | 282 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2010 | 600 | 0.020 |
Why?
|
| Nomograms | 1 | 2012 | 312 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2012 | 266 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 886 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 2045 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2011 | 9278 | 0.020 |
Why?
|
| Forecasting | 1 | 2012 | 699 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1993 | 579 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 5867 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2009 | 66 | 0.020 |
Why?
|
| Pneumonia | 1 | 2015 | 791 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2010 | 415 | 0.020 |
Why?
|
| Disease Progression | 1 | 2000 | 6880 | 0.020 |
Why?
|
| Nausea | 1 | 2010 | 537 | 0.020 |
Why?
|
| Receptors, Opioid, mu | 1 | 2009 | 96 | 0.020 |
Why?
|
| Hospitalization | 1 | 2017 | 2169 | 0.020 |
Why?
|
| Analgesia | 1 | 2009 | 95 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2012 | 476 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 2014 | 866 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 1559 | 0.020 |
Why?
|
| Anxiety | 1 | 2014 | 1244 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2002 | 14033 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2009 | 33840 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 3423 | 0.020 |
Why?
|
| Depression | 1 | 2014 | 1732 | 0.010 |
Why?
|
| Reimbursement Mechanisms | 1 | 2004 | 76 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2004 | 217 | 0.010 |
Why?
|
| Critical Illness | 1 | 2009 | 734 | 0.010 |
Why?
|
| Medical Records | 1 | 2004 | 441 | 0.010 |
Why?
|
| Medical History Taking | 1 | 2003 | 175 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 16242 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1989 | 5258 | 0.010 |
Why?
|
| Physical Examination | 1 | 2003 | 306 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2010 | 6231 | 0.010 |
Why?
|
| Celiac Plexus | 1 | 1989 | 15 | 0.010 |
Why?
|
| Splanchnic Nerves | 1 | 1989 | 14 | 0.010 |
Why?
|
| Intercostal Nerves | 1 | 1989 | 32 | 0.010 |
Why?
|
| Religion | 1 | 2000 | 95 | 0.010 |
Why?
|
| Bioethics | 1 | 2000 | 71 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2003 | 625 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1998 | 189 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2003 | 2360 | 0.010 |
Why?
|
| Length of Stay | 1 | 2004 | 1995 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 15274 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 2395 | 0.010 |
Why?
|
| Hematocrit | 1 | 1993 | 149 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 12974 | 0.010 |
Why?
|
| Risk Factors | 1 | 2003 | 17849 | 0.000 |
Why?
|